Amneal to virtually participate at upcoming investor conferences
Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (nyse: amrx) (the “company”) today announced that its management team will virtually attend the following investor conferences: raymond james institutional investors conference march 1, 2021 fireside chat – 3:00 p.m. eastern time barclays global healthcare conference march 10, 2021 fireside chat – 4:10 p.m. eastern time a live webcast of the presentations will be accessible through the investor relations section of the company's website at https://investors.amneal.com. a replay of the webcast will be posted shortly after the call and will be available for a limited time following the event. about amneal amneal pharmaceuticals, inc. (nyse: amrx), headquartered in bridgewater, nj, is a fully-integrated pharmaceutical company focused on the development, manufacturing and distribution of generic and specialty drug products. the company has operations in north america, asia, and europe, working together to bring high-quality medicines to patients primarily within the united states. amneal has an extensive portfolio of approximately 250 product families and is expanding its portfolio to include complex dosage forms, including biosimilars, in a broad range of therapeutic areas. the company also markets a portfolio of branded pharmaceutical products through its specialty segment focused principally on central nervous system and endocrine disorders. the company also owns 65% of avkare. avkare provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, primarily focused on serving the department of defense and the department of veterans affairs. avkare is also a packager and wholesale distributor of pharmaceuticals and vitamins to its retail and institutional customers who are located throughout the united states focused primarily on offering 340b-qualified entities products to provide consistency in care and pricing. for more information, visit www.amneal.com. forward-looking statements certain statements contained herein, regarding matters that are not historical facts, may be forward-looking statements (as defined in the private securities litigation reform act of 1995, as amended). such forward-looking statements include statements regarding management’s intentions, plans, beliefs, expectations or forecasts for the future, including, among other things, future operating results and financial performance, product development and launches, integration strategies and resulting cost reduction, market position and business strategy. words such as “may,” “will,” “could,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “assume,” “continue,” and similar words are intended to identify estimates and forward-looking statements. the reader is cautioned not to rely on these forward-looking statements. these forward-looking statements are based on current expectations of future events. if the underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of amneal. a list and descriptions of these risks, uncertainties and other factors can be found in the company’s most recently filed annual report on form 10-k for the fiscal year ended december 31, 2020, as supplemented by any subsequently filed quarterly reports on form 10-q. copies of these filings are available online at www.sec.gov, www.amneal.com or upon request from the company. forward-looking statements included herein speak only as of the date hereof and we undertake no obligation to revise or update such statements to reflect the occurrence of events or circumstances after the date hereof, except as otherwise required by united states securities laws.
